Vertex Pharmaceuticals Inc. buy Jefferies Financial Group Inc.
Start price
09.12.24
/
50%
€440.25
Target price
09.12.25
€519.86
Performance (%)
-15.62%
End price
10.12.25
€371.50
Summary
This prediction ended on 10.12.25 with a price of €371.50. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -15.62%. Jefferies_Financial_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -1.465% | -1.465% | 3.309% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by Jefferies_Financial_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $550.00 price target on the stock, up previously from $500.00.
Ratings data for VRTX provided by MarketBeat
Current prediction by Jefferies_Financial_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€426.65
10.03.26
10.03.26
€498.92
10.03.27
10.03.27
-3.05%
31.07.26
31.07.26
